178 related articles for article (PubMed ID: 37291428)
41. Watch and wait approach in rectal cancer: Current controversies and future directions.
López-Campos F; Martín-Martín M; Fornell-Pérez R; García-Pérez JC; Die-Trill J; Fuentes-Mateos R; López-Durán S; Domínguez-Rullán J; Ferreiro R; Riquelme-Oliveira A; Hervás-Morón A; Couñago F
World J Gastroenterol; 2020 Aug; 26(29):4218-4239. PubMed ID: 32848330
[TBL] [Abstract][Full Text] [Related]
42. Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer.
Lopez-Lopez V; Abrisqueta J; Lujan J; Hernandez Q; Ono A; Parrilla P
Saudi J Gastroenterol; 2016; 22(2):148-53. PubMed ID: 26997222
[TBL] [Abstract][Full Text] [Related]
43. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB
JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084
[TBL] [Abstract][Full Text] [Related]
44. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study.
Li J; Liu H; Yin J; Liu S; Hu J; Du F; Yuan J; Lv B; Fan J; Leng S; Zhang X
Oncotarget; 2015 Dec; 6(39):42354-61. PubMed ID: 26472284
[TBL] [Abstract][Full Text] [Related]
45. Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
Liu S; Zhong GX; Zhou WX; Xue HD; Pan WD; Xu L; Lu JY; Wu B; Lin GL; Qiu HZ; Xiao Y
Dis Colon Rectum; 2018 Aug; 61(8):903-910. PubMed ID: 29944579
[TBL] [Abstract][Full Text] [Related]
46. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes.
Neşşar G; Demirbağ AE; Mısırlıoğlu HC; Sezer S
Turk J Gastroenterol; 2019 Nov; 30(11):951-956. PubMed ID: 31767549
[TBL] [Abstract][Full Text] [Related]
47. Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
Balasuriya HD; Timon C; Entriken F; Neely D; Herron J; Tang C; Van Hazel G; Warner MW
ANZ J Surg; 2022 Nov; 92(11):2961-2967. PubMed ID: 35841184
[TBL] [Abstract][Full Text] [Related]
48. Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
Marchegiani F; Palatucci V; Capelli G; Guerrieri M; Belluco C; Rega D; Morpurgo E; Coco C; Restivo A; De Franciscis S; Aschele C; Perin A; Bonomo M; Muratore A; Spinelli A; Ramuscello S; Bergamo F; Montesi G; Spolverato G; Del Bianco P; Gambacorta MA; Delrio P; Pucciarelli S
Ann Surg Oncol; 2022 Mar; 29(3):1880-1889. PubMed ID: 34855063
[TBL] [Abstract][Full Text] [Related]
49. Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy.
Chino A; Konishi T; Ogura A; Kawachi H; Osumi H; Yoshio T; Kishihara T; Ide D; Saito S; Igarashi M; Akiyoshi T; Ueno M; Fujisaki J
Eur J Surg Oncol; 2018 Aug; 44(8):1247-1253. PubMed ID: 29731188
[TBL] [Abstract][Full Text] [Related]
50. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
Park H; Kim KA; Jung JH; Rhie J; Choi SY
Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
[TBL] [Abstract][Full Text] [Related]
51. Total neoadjuvant therapy followed by a watch-and-wait strategy for patients with rectal cancer (TOWARd): protocol for single-arm phase II/III confirmatory trial (JCOG2010).
Hashimoto T; Tsukamoto S; Murofushi K; Ito Y; Hirano H; Tsukada Y; Sasaki K; Mizusawa J; Fukuda H; Takashima A; Kanemitsu Y
BJS Open; 2023 Nov; 7(6):. PubMed ID: 37931233
[TBL] [Abstract][Full Text] [Related]
52. Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer.
Beard BW; Rettig RL; Ryoo JJ; Parker RA; McLemore EC; Attaluri V
J Am Coll Surg; 2020 Dec; 231(6):681-692. PubMed ID: 33121903
[TBL] [Abstract][Full Text] [Related]
53. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
[TBL] [Abstract][Full Text] [Related]
54. Surgery may not benefit patients with locally advanced rectal cancer who achieved clinical complete response following neoadjuvant chemoradiotherapy.
Han Z; Li M; Chen J; Ji D; Zhan T; Peng Y; Xue W; Li Y; Cai Y; Sun Y; Wu Q; Du C; Gu J
Asian J Surg; 2022 Jan; 45(1):97-104. PubMed ID: 33888366
[TBL] [Abstract][Full Text] [Related]
55. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
56. [Guiding significance of pathological diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].
Li ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):248-251. PubMed ID: 32192303
[TBL] [Abstract][Full Text] [Related]
57. Salvage surgery for local regrowths in Watch & Wait - Are we harming our patients by deferring the surgery?
Nasir I; Fernandez L; Vieira P; Parés O; Santiago I; Castillo-Martin M; Domingos H; Cunha JF; Carvalho C; Heald RJ; Beets GL; Parvaiz A; Figueiredo N
Eur J Surg Oncol; 2019 Sep; 45(9):1559-1566. PubMed ID: 31006589
[TBL] [Abstract][Full Text] [Related]
58. [Application of imaging diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].
Zhang XY; Lu QY; Sun YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):243-247. PubMed ID: 32192302
[TBL] [Abstract][Full Text] [Related]
59. Watch and Wait for rectal cancer in inflammatory bowel disease.
Azevedo JGM; Fernandez L; Herrando AI; Santiago I; Pares O; Parvaiz A
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429643
[TBL] [Abstract][Full Text] [Related]
60. Watch and Wait Strategy for Rectal Cancer: How Long Should We Wait for a Clinical Complete Response?
Asoglu O; Goksoy B; Aliyev V; Mustafayev TZ; Atalar B; Bakir B; Guven K; Demir G; Goksel S
Surg Technol Int; 2022 May; 40():130-139. PubMed ID: 35090178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
